eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, Delphine Allard, Oskar Hemmingsson, Gorana Tomasic, Marina Thomas, Christine Basmadjian, Nigel Ribeiro, Frédéric Thuaud, Christina Mateus, Emilie Routier, Nyam Kamsu-Kom, Sandrine Agoussi, Alexander M. Eggermont, Laurent Désaubry, Caroline Robert, Stéphan Vagner

Research output: Contribution to journal › Article › peer-review

280 Citations (Scopus)

Fingerprint

Dive into the research topics of 'eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science